Literature DB >> 30449814

Isolated Orbital Myeloid Sarcoma as a Therapy-related Myeloid Neoplasm.

Kazuya Ishiguro1, Tohru Takahashi1.   

Abstract

Entities:  

Keywords:  orbital myeloid sarcoma; therapy-related myeloid neoplasm

Year:  2018        PMID: 30449814      PMCID: PMC6478994          DOI: 10.2169/internalmedicine.2105-18

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
Therapy-related orbital myeloid sarcoma is very rare (1). A 61-year-old woman was admitted because of protrusion of the right eyeball (Picture 1). Computed tomography revealed a mass lesion in the right orbit that showed the uptake of 18F-fluorodeoxyglucose on positron emission tomography (Picture 2). A biopsy of the right orbit mass revealed proliferation of atypical cells that were positive for myeloperoxidase (Picture 3). A bone marrow examination showed neither an increase in blasts nor myelodysplasia. A diagnosis of myeloid sarcoma confined to the right orbit was made. She had a history of ovarian carcinoma treated with irinotecan and cisplatin 10 years earlier, so her disease was classified as therapy-related myeloid neoplasm (2). She received remission-induction chemotherapy for acute myeloid leukemia (idarubicin plus cytarabine) followed by a consolidation radiotherapy toward the right orbit. After the treatment, the protrusion of the right eyeball was markedly improved (Picture 4).
Picture 1.
Picture 2.
Picture 3.
Picture 4.
The authors state that they have no Conflict of Interest (COI).
  1 in total

1.  Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experience.

Authors:  Deniz Peker; Vishwas Parekh; Ravikumar Paluri; Taylor Deal; Uma Borate; Antonio Di Stasi; Shuko Harada; Emmanuel Agosto Arroyo; Vishnu Reddy
Journal:  Int J Hematol       Date:  2014-09-11       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.